Q036Y5 AF NFT

GMP synthase [glutamine-hydrolyzing]

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifrahaxlotknjnke3xqs7c6333jsnwiskvchpzgfssj2kl54nrxpa/metadata.json
IPFS of structure file: 
bafybeiar3nq76yikr6uoegchf2i3z74sluov5muu377jfnlrml4y2txaiy/AF-Q036Y5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x93f7e5ac43dcB2b93e5c93f453853F747a7d35AB
First NFT owner address (bech32): 
genesis1j0m7ttzrmjetj0juj0698pflw3a86ddtvxk9cu
Current NFT ID #161504 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
161504
Accession (UniProt):
Q036Y5
Name::
GMP synthase [glutamine-hydrolyzing]
Experimental Method:
Predicted structure
Sequence source:
Lacticaseibacillus paracasei (strain ATCC 334 / BCRC 17002 / CCUG 31169 / CIP 107868 / KCTC 3260 / NRRL B-441)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q036Y5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q036Y5|GUAA_LACP3 GMP synthase [glutamine-hydrolyzing] OS=Lacticaseibacillus paracasei (strain ATCC 334 / BCRC 17002 / CCUG 31169 / CIP 107868 / KCTC 3260 / NRRL B-441) OX=321967 GN=guaA PE=3 SV=1 MANDQNKDYDKIIVLDYGSQYNQLITRRIREFGIYSELKPHTITAAEVKKIAPKGIIFSGGPNSVYDEGALGVDEDLFKLGIPILGVCYGMQLMAQRLGGDVEPADNREYGKADIEVTDDSAKLFRDLPKDQTVWMSHGDLVTRVPEGFRRTATSINCPISAMDDDDRKFYGIQFHAEVQNTQYGHEILHHFAFDICKAEANWSMDDFITKQIDKIRAEVGDKRVLLGLSGGVDSSVVGVLLHKAIGTQLTSIFVDHGLLRKGEADQVMESLKGKFGLNIIKVNAKDRFLGDLKGVTDPEKKRKIIGRDFIEVFNEEAAKLNGIDFLAQGTLYTDVVESGTDTAQTIKSHHNVGGLPEDLKFKLIEPLNKLFKDEVRELGEKLGMPHALVWRQPFPGPGLGIRVIGEVTEDKLEIVRDSDYILREEIAKHGLDKDIWQYFTVLPGFRSVGVMGDGRTYDYTIGIRAITSIDGMTADFARINWDVLQEISSRIVNEVKNVNRVVYDITSKPPATIEWE